Danaher Corporation provided earnings guidance for third quarter 2022. For the quarter the company expected to deliver high single-digit core revenue growth in base business. The company expects a mid-single-digit core revenue growth headwind from COVID-19 testing, resulting in low single-digit core revenue growth overall.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
235.5 USD | -0.36% | -1.85% | +1.80% |
Apr. 17 | AdaptHealth Names Suzanne Foster as CEO | MT |
Apr. 17 | AdaptHealth Names Suzanne Foster CEO | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.80% | 175B | |
+2.64% | 207B | |
+8.59% | 132B | |
+16.47% | 99.1B | |
-3.42% | 60.89B | |
+12.71% | 52.04B | |
-6.61% | 45.48B | |
-4.53% | 38.81B | |
+9.27% | 38.77B | |
+3.97% | 26.09B |
- Stock Market
- Equities
- DHR Stock
- News Danaher Corporation
- Danaher Corporation Provides Earnings Guidance for Third Quarter 2022